» Articles » PMID: 2613338

Incidence of Strains Producing Extended Spectrum Beta-lactamases in Argentina

Overview
Journal Infection
Date 1989 Nov 1
PMID 2613338
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of strains producing transferable beta-lactamases capable of hydrolyzing third generation cephalosporins or aminothiazole-oximino substituted monobactams in five Buenos Aires hospitals during a four month period was studied. These enzymes were categorized by 1) MIC greater than or equal to 1 mg/l for third generation cephalosporins; 2) MIC less than 0.06 mg/l for third generation cephalosporins combined with clavulanic acid or sulbactam; 3) sensitivity to imipenem or cephamycins (excluding permeability mutants); and 4) transferable resistance by conjugation. Beta-lactamases hydrolyzing aminothiazole-oximino substituted monobactams were produced by 17.2% of Enterobacteriaceae from intensive care unit patients; 3.6% from inpatients of other units and 1.2% from outpatients. Producers were mainly Klebsiella spp. (45/46) resistant to aminoglycosides (most of them AAC 3'-AAC 6' producers). Three strains had a an isoelectric point of 6.0, two of 6.5 and three of 7.7. TEM-1 beta-lactamase (isoelectric point 5.4) was detected in 6/8 strains. An inocolum effect was observed in 40/46 strains. A Klebsiella pneumoniae strain preserved since 1982 also produced a transferable beta-lactamase hydrolyzing aminothiazole-oximino substituted monobactams.

Citing Articles

Antimicrobial Susceptibility and Genetic Prevalence of Extended-Spectrum β-Lactamases in Gram-Negative Rods Isolated from Clinical Specimens in Pakistan.

Idrees M, Rimsha R, Idrees M, Saeed A Antibiotics (Basel). 2023; 12(1).

PMID: 36671229 PMC: 9854846. DOI: 10.3390/antibiotics12010029.


Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America.

Guzman-Blanco M, Labarca J, Villegas M, Gotuzzo E Braz J Infect Dis. 2014; 18(4):421-33.

PMID: 24389277 PMC: 9427466. DOI: 10.1016/j.bjid.2013.10.005.


Extended-spectrum beta-lactamases: a clinical update.

Paterson D, Bonomo R Clin Microbiol Rev. 2005; 18(4):657-86.

PMID: 16223952 PMC: 1265908. DOI: 10.1128/CMR.18.4.657-686.2005.


Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Moland E, Black J, Ourada J, Reisbig M, Hanson N, Thomson K Antimicrob Agents Chemother. 2002; 46(12):3837-42.

PMID: 12435685 PMC: 132764. DOI: 10.1128/AAC.46.12.3837-3842.2002.


BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.

Sanders C, Ehrhardt A, Moland E, Thomson K, Zimmer B, Roe D J Clin Microbiol. 2002; 40(1):123-7.

PMID: 11773104 PMC: 120116. DOI: 10.1128/JCM.40.1.123-127.2002.


References
1.
Lesage D, GERBAUD G, CHABBERT Y . [Genetic map and structure in "Escherichia coli" K12 of a resistance plasmid isolated from "Salmonella ordonez" (author's transl)]. Ann Microbiol (Paris). 1975; 126A(4):435-48. View

2.
STEERS E, FOLTZ E, GRAVES B . An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot Chemother (Northfield). 2014; 9(5):307-11. View

3.
Jarlier V, Nicolas M, Fournier G, Philippon A . Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988; 10(4):867-78. DOI: 10.1093/clinids/10.4.867. View

4.
. [Statement of the Antibiogram Committee of the French Microbiological Society]. Pathol Biol (Paris). 1985; 33(5):295-6. View